Clinical Trial Update: Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease [Phase 3]

View source ↗

Summary

Phase 3 study of Denufosol Tetrasodium Inhalation Solution in cystic fibrosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Denufosol Tetrasodium Inhalation Solution (denufosol tetrasodium)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED